Moreover, the cardioprotective properties of GLP-1 RAs have been manifested in terms of reducing hypertension, hyperlipidemia, and cardiac arrythmias; controlling these factors plays a key role in the CV risk mitigating strategies. Here, GCG is linked to hyperlipidemia.